A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000037:antagonists & inhibitors / Q000097:blood / Q000627:therapeutic use*; D001412:Bacillus subtilis / Q000187:drug effects; D007939:Leukemia L1210 / Q000188:drug therapy*; D007942:Leukemia, Experimental / Q000188:drug therapy; D051379:Mice; D010069:Oxadiazoles / Q000627:therapeutic use*; D010080:Oxazoles / Q000037:antagonists & inhibitors / Q000097:blood
D000903:Antibiotics, Antineoplastic; D010069:Oxadiazoles; D010080:Oxazoles